Healthcare Burden of Medication-Overuse Headache in Patients with Migraine

Author(s)

Thomson H1, Sullivan C1, Anderson C1, Cady R2, Lipton R3, Smith T4, Kymes S1
1Lundbeck, Deerfield, IL, USA, 2Lundbeck Seattle BioPharmaceuticals, Inc., Bothell, WA, USA, 3Albert Einstein College of Medicine, Bronx, NY, USA, 4StudyMetrix Research, St. Peters, MO, USA

OBJECTIVES : Medication-overuse headache (MOH), the worsening of a pre-existing headache disorder from frequent use of medications to treat primary headache disorders, can be disabling and costly. Characteristics and healthcare costs in patients with MOH + migraine vs migraine only were compared to study the additional burden of MOH vs migraine alone.

METHODS : Patients diagnosed with migraine with or without (MOH identified from ICD-10 code G44.40 [drug-induced headache]) between 1/1/2019 and 12/31/2019 were identified using the IBM MarketScan Commercial Research Database. Demographics, comorbidities, hospitalization claims, and costs were analyzed. Hospitalization costs were based only on inpatient claims. Annual healthcare costs included inpatient, outpatient, and drug costs, and were adjusted for age, sex, healthcare plan type, and Charlson Comorbidity Index (CCI) using gamma distribution and log link.

RESULTS : Data from 524,417 eligible patients were examined (520,794 migraine only; 3623 MOH + migraine). The groups were similar in age (mean, 40–41 years), sex (women, 80%–84%), and healthcare plan type (employer, 76%–79%). There were no meaningful between-group differences in individual comorbidities, but the mean (SD) CCI was slightly higher in patients with MOH + migraine vs migraine only (0.056 [0.30]) vs 0.050 [0.30]). Hospitalizations were more frequent in the MOH + migraine group vs migraine only (8.5% vs 6.3%). Hospitalization costs in those hospitalized were similar in both groups ($34,957–$36,464). Mean total unadjusted annual costs were higher for MOH + migraine vs migraine only ($18,471 vs $11,757). These cost differences were statistically significant before and after covariate adjustments (P<0.0001).

CONCLUSIONS : This study found that MOH was rarely coded in people with migraine (0.69%), suggesting it is under-coded. Patients with MOH + migraine had a greater likelihood of hospitalization and 57% higher annual healthcare costs vs patients with migraine only. Further studies examining the diagnosis and coding of MOH are warranted.

Conference/Value in Health Info

2021-05, ISPOR 2021, Montreal, Canada

Value in Health, Volume 24, Issue 5, S1 (May 2021)

Code

PND19

Topic

Economic Evaluation

Disease

Neurological Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×